MedTrace Logo

Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)

NCT01978561 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-09-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate pregnancy, delivery, and neonatal outcomes in subjects who maintain ongoing clinical pregnancies through Week 10 of gestation in NT-03.

Conditions

  • Repeated IVF Failure

Interventions

BIOLOGICAL

Post dosing with NT100

OTHER

Post dosing with Placebo

Sponsors & Collaborators

  • Nora Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-08-31
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01978561 on ClinicalTrials.gov